Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Kapake
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Kapake 30mg/500mg tablets
0407010F0BHAAAH
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 2,889 |
|
Kapake 30mg/500mg capsules
0407010F0BHADAD
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 1,313 |
|
Kapake 15mg/500mg tablets
0407010F0BHAFAK
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Kapake 30mg/500mg effervescent tablets
0407010F0BHAEAF
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Kapake Insts 30mg/500mg effervescent powder sachets
0407010F0BHABAQ
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Kapake Insts 60mg/1000mg effervescent powder sachets
0407010F0BHACAR
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.